1. Home
  2. INKT

INKT

MiNK Therapeutics Inc.

Logo MiNK Therapeutics Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Founded: 2017 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 34.7M IPO Year: 2021
Target Price: $9.00 AVG Volume (30 days): 104.3K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.65 EPS Growth: N/A
52 Week Low/High: $0.75 - $3.34 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: